English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, February 12, 2021
APOLLOMICS(冠科美博)在中国和南非引进一款靶向主动免疫检查点控制剂重组疫苗
Thursday, February 11, 2021
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
APOLLOMICS(冠科美博)從ITERION THERAPEUTICS引進TEGAVIVINT
APOLLOMICS(冠科美博)从ITERION THERAPEUTICS引进TEGAVIVINT
Wednesday, February 10, 2021
APOLLOMICS(冠科美博)从EDISON ONCOLOGY引进一款创新实体瘤酪氨酸蛋白激酶抑制剂
APOLLOMICS(冠科美博)從EDISON ONCOLOGY引進一款創新實體瘤酪氨酸蛋白激酶抑制劑
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors
Wednesday, February 3, 2021
兩個移民,一項獨特的生物製藥創業計畫
两个移民,一项独特的生物制药创业计划
Two Immigrants, One Unique Plan For A Biopharma

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575